Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Regulatory Lawyers Lead Charge in China-Europe M&A Rebound

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

MoFo’s Global Co-Chair of Private Equity Group Marcia Ellis and Private Equity/M&A associate Yilong Luo were quoted in a...

About Morrison Foerster

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

MoFo’s Global Co-Chair of Private Equity Group Marcia Ellis and Private Equity/M&A associate Yilong Luo were quoted in a Mergermarket article titled “Regulatory Lawyers Lead Charge in China-Europe M&A Rebound.”According to Marcia, as Europe remains wary of Chinese investments’ impact on European industries, changes to European foreign direct investment (FDI) regulations to make it easier for Chinese investors to invest in Europe are not yet on the agenda, despite the shift in political sentiment and investment appetite.Yilong echoed this situation by discussing the proactive strategies Chinese investors are employing to navigate the complex regulatory landscape. “A lot of Chinese investors now have a strong self-awareness of what targets to spend their time and money on…This contrasts to the years previous, when not much thought was given.” said Yilong.The article also reports a significant increase in China-Europe deal volume, tripling in 2024 compared to the previous year and reaching EUR 28.5 billion. This growth is driven by Chinese investors seeking diversification, access to advanced technology and broader market opportunities in Europe.Read the <a href="https://mergermarket.ionanalytics.com/content/1004241313" target="_blank">full article</a> (subscription required).

Regulatory Lawyers Lead Charge in China-Europe M&A Rebound

Sign Up

Marcia Ellis is a Senior Counsel in our New York office and a Partner in our Hong Kong office. Marcia’s practice focuses on private equity transactions and complex mergers and acquisitions involving companies and other assets located in Asia. Having practiced in Asia for more than a quarter of a century, Marcia is one of the most experienced M&A lawyers active in the Asian market. In the past three years, she has advised clients on deals with a total aggregate value well in excess of US$249.8 billion.​Marcia regularly advises leading investors on M&A transactions, including SoftBank Vision Fund, Alibaba, GLP, Bain Capital, BlackRock, Farallon Capital, Ascendent Capital Partners, Silver Crest Acquisition Corp., PAG, Hillhouse, Hony Capital and Celadon Partners. In addition, she is experienced in representing U.S., UK and Asia based institutional investors in the acquisition, financing and disposition of real estate in China, Hong Kong and elsewhere in Asia, including numerous logistics and internet data center projects, and investment in and acquisition of real estate developers.From 2008 through 2011, she was the Chief Legal Officer for Asia of D. E. Shaw, where she assisted various group entities in making, restructuring, and exiting investments in various countries in Asia, including a number of significant and highly structured investments in China and India.Clients consider Marcia as a "super skilled technical lawyer" who offers "incredible problem-solving skills on all aspects of matters, both legal and commercial". A client said that "Finding a lawyer whose judgement you trust and who knows how far they can push the boundaries is not easy, and Marcia is the best lawyer I've worked with."Marcia is the Global Co-Chair of the firm’s Private Equity Practice, a member of our global board of directors, and a member of our global Environmental, Social and Governance (ESG) Steering Committee. She has also been named to Law360’s 2022 and 2023 Private Equity Editorial Board and elected as the Co-Chair of AmCham Hong Kong’s Women of Influence Committee. Marcia has been recognized as one of the Women of Influence in Private Markets: Private Equity by Private Equity International in 2024.

Marcia Ellis（艾琳）律师的执业重点是涉及亚洲境内公司和其它资产的私募股权交易和复杂并购。Ellis律师在亚洲执业超过二十五年，是活跃在亚洲市场经验最丰富的并购律师之一。在过去三年间，她为客户完成的交易的合计价值超过2498亿美元。Ellis律师经常为大型投资者提供并购交易法律咨询，这些投资者包括软银愿景基金、阿里巴巴、普洛斯、Bain Capital、贝莱德、Farallon Capital、上达资本、Silver Crest特殊目的收购公司、PAG、高瓴资本、弘毅投资以及Celadon Partners。此外，在代表美国、英国、亚洲机构投资人方面她也富有经验；她代表客户处理收购、融资、处置中国、香港及亚洲其它地区的房地产，其中包括许多物流和互联网数据中心项目，也处理对房地产开发商的投资与收购。从2008至2011年，Ellis律师是德劭集团亚洲区的首席法务官。在德劭集团，她协助各集团实体处理在亚洲多个国家进行的投资、投资重组及投资退出事宜，包括在中国和印度进行的多个重要及高度结构化的投资。客户评价Ellis律师是一位"技巧高超的律师"，她拥有 "极其出色的解决问题的能力，包括法律问题和商业问题 "。一位客户称："找到一位拥有令人信任的判断力，并能尽力突破极限的律师并不容易，而她是我合作过的最好的律师"。Ellis律师是美富律师事务所的全球私募股权业务联席主席，本所全球董事会成员，兼本所环境、社会与治理（ESG）指导委员会委员之一。她还当选《法律360》（Law 360）2022年度和2023年度私募股权业务编辑委员会成员，以及香港美国商会最具影响力女性（WOI）指导委员会联席主席。Ellis律师还荣获Private Equity International评为2024年“私募股权领域：私募市场最具影响力女性”之一。

Marcia Ellis

Senior Counsel (New York) | Partner (Hong Kong)

Yilong’s practice focuses on mergers and acquisitions, private equity investments, as well as other general corporate matters.Yilong received a J.D. cum laude from Cornell Law School in 2017, where he was a notes editor of the Cornell Law Review.Yilong is a Registered Foreign Lawyer with the Law Society of Hong Kong. Prior to joining MoFo, he practiced in New York and London as an associate of two leading international firms. He is fluent in Mandarin and English.<h4>Representative Experience:</h4><ul><li>A leading private equity firm in its US$500 million partnership with Temasek, including Temasek taking a minority stake in the client, and a multi-fund investment by Temasek to anchor the client’s future funds.</li><li>A special purpose acquisition company in its US$300 million initial public offering and subsequent search for acquisition opportunities.</li><li>A U.S.-based pharmaceutical company in an up-C merger with Amneal Pharmaceuticals (NYSE: AMRX).</li><li>A leading private equity firm in its fund’s divestment of the majority of its holding in Orchid Orthopedic Solutions to Nordic Capital Fund IX.</li><li>A London-based family office in its strategic minority investments in EagleTree Capital.</li></ul>

罗亦龙律师的业务主要侧重于收购合并、私募股权投资，以及其他一般公司事宜。罗律师于2017年获得康奈尔大学法学院的法律博士学位，并以优等成绩毕业。他曾担任《康奈尔法律评论》的笔记编辑。罗律师是香港律师会注册外国律师。在加入美富前，罗律师曾分别在纽约与伦敦的两所顶尖国际律所担任律师。罗律师精通普通话与英语。<h4>具有代表性的项目：</h4><ul><li>代表某领先的私募股权公司处理其与淡马锡之间的5亿美元合作事宜，包括淡马锡收购其少数股权，以及淡马锡对多只基金作出投资，从而成为其未来基金的锚定投资者。</li><li>代表某特殊目的收购公司处理其3亿美元的首次公开发行，以及其后物色收购机会的事宜。</li><li>代表某位于美国的制药公司处理其与Amneal Pharmaceuticals（纽交所：AMRX）作出UP-C合并的事宜。</li><li>代表某领先的私募股权公司处理其设立的基金将其大部分Orchid Orthopedic Solutions的股权剥离并售予Nordic Capital Fund IX的事宜。</li><li>代表某位于伦敦的家族办公室处理其对EagleTree Capital作出战略性少数股权投资的事宜。</li></ul>